[1] 王化, 王伟, 唐光健.肝细胞癌影像学诊断的现状与进展[J].中华放射学杂志, 2006, 40(3): 315-318.
[2] Efremidis SC, Hytiroglou P. The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation[J]. Eur Radiol, 2002, 12(4): 753-764.
[3] Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology[J]. J Gastroenterol, 2009, 44 Suppl 19: S112-118.
[4] 刘树堂, 齐晓辉, 时高峰, 等.多种影像学检查技术对小肝癌的综合诊断研究[J].河北医药, 2013, 35(4): 526-527.
[5] 许万博, 刘小金.磁共振动态增强技术在小肝癌诊断中的应用价值[J].德州学院学报, 2012, 28(6): 45-47.
[6] Buadu LD, Murakami J, Murayama S, et al. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis[J]. J Comput Assist Tomogr, 1997, 21(3): 421-430.
[7] Wang B, Gao ZQ, Yan X. Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma[J]. Acta Radiol, 2005, 46(4): 353-358.
[8] 于德新, 马祥兴, 魏华刚, 等. 3.0 T动态增强MR评价肝细胞癌血管生成及其成熟度的价值[J].临床放射学杂志, 2009, 28(3): 355-359.
[9] Hsu CY, Shen YC, Yu CW, et al. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil[J]. J Hepatol, 2011, 55(4): 858-865.
[10] Bachmann R, Kreft B, Dombrowski F, et al. Enhanced tumor detection in the presence of liver cirrhosis: experimental study on the diagnostic value of a superparamagnetic iron oxide MR imaging contrast agent(NSR 0430)[J]. J Magn Reson Imaging, 1999, 9(2): 251-256.
[11] Paley MR, Mergo PJ, Torres GM, et al. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging[J]. AJR Am J Roentgenol, 2000, 175(1): 159-163.
[12] Stadlbauer A, Nimsky C, Gruber S, et al. Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study[J]. AJNR Am J Neuroradiol, 2007, 28(3): 462-469.
[13] Sinba S, Bastin ME, Wardlaw JM, et al. Effects of dexamethasone on peritumoural oedematous brain: a DT-MRI study[J]. J Neurol Neurosurg Psychiatry, 2004, 75(11): 1632-1635.
[14] 张洁, 赵天佐, 赵琴利, 等.肝硬化相关小肝癌的血供特点和MRI表现[J].中国中西医结合影像学杂志, 2013, 11(1): 1-3, 6.
[15] Bolog N, Andreisek G, Oancea I, et al. CT and MR imaging of hepatocellular carcinoma[J]. J Gastrointestin Liver Dis, 2011, 20(2): 181-189.
[16] Lee NK, Kim S, Lee JW, et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications[J]. Radiographics, 2009, 29(6): 1707-1724.
[17] Ringe KI, Husarik DB, Sirlin CB, et al. Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver[J]. AJR Am J Roentgenol, 2010, 195(1): 13-28.
[18] Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update[J]. Hepatology, 2011, 53(3): 1020-1022.
[19] Kim HY, Choi JY, Kim CW, et al. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis[J]. Liver Transpl, 2012, 18(7): 850-857.
[20] Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging[J]. Eur Radiol, 2011, 21(10): 2056-2066.
[21] Motosugi U, Ichikawa T, Sano K, et al. Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease[J]. J Magn Reson Imaging, 2011, 34(1): 88-94.
[22] 梁坚豪, 赵继泉, 曾惠良, 等.磁共振灌注成像对肝硬化增生性结节与小肝癌的鉴别诊断[J].临床医学工程, 2012, 19(11): 1863-1865.
[23] Rao SX, Chen CZ, Liu H, et al. Three-dimensional whole-liver perfusion magnetic resonance imaging in patients with hepatocellular carcinomas and colorectal hepatic metastases[J]. BMC Gastroenterol, 2013, 13: 53.
[24] Jin N, Deng J, Chadashvili T, et al. Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis[J]. Radiology, 2010, 254(1): 129-137.
[25] Boulanger Y, Amara M, Lepanto L, et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients[J]. NMR Biomed, 2003, 16(3): 132-136.
[26] 黄泽光, 谢长浓, 吴永峻. MR弥散加权成像诊断肝硬化不典型癌变结节[J].中国医学影像技术, 2010, 26: 701-703.
[27]

范义.肝癌化疗栓塞前后MR弥散和灌注成像的实验研究[D].广州: 南方医科大学, 2009.
[28] Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging[J]. J Magn Reson Imaging, 2005, 22(4): 439-450.
[29] Zhang J, Krinsky GA. Iron-containing nodules of cirrhosis[J]. NMR Biomed, 2004, 17(7): 459-464.
[30] 曾蒙苏, 李若坤.磁共振磁敏感加权成像在肝硬化结节多步癌变中的临床应用[J].临床肝胆病杂志, 2013, 29(1): 38-41.
[31] 张龙江, 祁吉.肾的血氧水平依赖功能磁共振成像[J].中国中西医结合影像学杂志, 2007, 5(2): 42-45.
[32] Robinson SP, Rodrigues LM, Griffiths JR, et al. Response of hepatoma 9618a and normal liver to host carbogen and carbon monoxide breathing[J]. Neoplasia, 1999, 1(6): 537-543.
[33] Foley LM, Picot P, Thompson RT, et al. In vivo monitoring of hepatic oxygenation changes in chronically ethanol-treated rats by functional magnetic resonance imaging[J]. Magn Reson Med, 2003, 50(5): 976-983.
[34] Semple SI, Wallis F, Haggarty P, et al. The measurement of fetal liver T in utero before and after maternal oxygen breathing: progress towards a non-invasive measurement of fetal oxygenation and placental function[J]. Magn Reson Imaging, 2001, 19(7): 921-928.
[35] Neeman M, Dafni H, Bukhari O, et al. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy[J]. Magn Reson Med, 2001, 45(5): 887-898.
[36] Orrego H, Blendis LM, Crossley IR, et al. Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat[J]. Gastroenterology, 1981, 80(3): 546-556.
[37] Jin N, Deng J, Chadashvili T, et al. Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis[J]. Radiology, 2010, 254(1): 129-137.
[38] Robinson SP, Rodrigues LM, Ojugo AS, et al. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging[J]. Br J Cancer, 1997, 75(7): 1000-1006.
[39] Robinson SP, Rodrigues LM, Griffiths JR, et al. Response of hepatoma 9618a and normal liver to host carbogen and carbon monoxide breathing[J]. Neoplasia, 1999, 1(6): 537-543.
[40] Rhee TK, Larson AC, Prasad PV, et al. Feasibility of blood oxygenation level-dependent MR imaging to monitor hepatic transcatheter arterial embolization in rabbits[J]. J Vasc Interv Radiol, 2005, 16(11): 1523-1528.
[41] 于德新, 马祥兴, 魏华刚, 等.利用R2*、T2*值无创评估肝细胞癌血氧水平与血管生成及其成熟度的关系[J].中国医学科学院学报, 2009, 31(5): 589-593.